Literature DB >> 9259435

New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis.

L M Pachman1, J R Hayford, M C Hochberg, M A Pallansch, A Chung, C D Daugherty, B H Athreya, S L Bowyer, C W Fink, H L Gewanter, R Jerath, B A Lang, I S Szer, J Sinacore, M L Christensen, A R Dyer.   

Abstract

OBJECTIVE: To determine, in a case-control study, if patients with new-onset juvenile dermatomyositis (juvenile DM) have increased symptoms prior to onset, exposure to certain environmental conditions, frequency of familial autoimmune diseases, or antibody titers, compared with 2 control groups.
METHODS: A structured interview with the families of 80 children with juvenile DM, 40 children with juvenile rheumatoid arthritis (JRA), or 23 healthy children, from the same geographic area as the children with juvenile DM, was conducted. All children's sera were tested for antibody to Toxoplasma gondii, herpes simplex virus (HSV), or coxsackievirus B (CVB).
RESULTS: A high proportion of children with juvenile DM had constitutional symptoms 3 months before the disease-onset date (P = 0.013 versus control children). Children with JRA had more relatives with rheumatoid arthritis (P = 0.0001) and pernicious anemia (P = 0.003) than did children with juvenile DM or healthy children. Among children < or =7 years of age, elevated enteroviral titers were more frequent in those with juvenile DM (81%) and in healthy controls (90%) than in those with JRA (64%), suggesting a common environmental exposure. Titers to T gondii, HSV, or CVB 1-6 were normal.
CONCLUSION: Frequencies of familial autoimmune disease, exposure to environmental factors, or elevated antibody titers to T gondii, HSV, or CVB are not increased in juvenile DM. Children with juvenile DM do have symptoms of illness 3 months before the disease-onset date, and young patients have elevated enteroviral titers, as do young geographic controls.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259435     DOI: 10.1002/art.1780400822

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

1.  An unspecific immunostimulating agent and juvenile dermatomyositis: enhanced T-cell proliferation and reverse immunosuppression as a severe adverse drug reaction.

Authors:  Gerd M Lackmann; Jenny Ndagijimana; Tim Niehues
Journal:  Eur J Pediatr       Date:  2003-08-07       Impact factor: 3.183

2.  Acute and chronic disease caused by enteroviruses.

Authors:  Julian W Tang; Christopher W Holmes
Journal:  Virulence       Date:  2017-03-31       Impact factor: 5.882

Review 3.  Juvenile dermatomyositis: the association of the TNF alpha-308A allele and disease chronicity.

Authors:  L M Pachman; T O Fedczyna; T S Lechman; J Lutz
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

4.  Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians.

Authors:  Gulnara Mamyrova; Terrance P O'Hanlon; Jason B Monroe; Danielle Mercatante Carrick; James D Malley; Sharon Adams; Ann M Reed; Ejaz A Shamim; Laura James-Newton; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2006-12

Review 5.  Familial autoimmunity and the idiopathic inflammatory myopathies.

Authors:  E A Shamim; F W Miller
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

Review 6.  The heterogeneity of juvenile myositis.

Authors:  Lisa G Rider
Journal:  Autoimmun Rev       Date:  2006-09-05       Impact factor: 9.754

Review 7.  Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.

Authors:  Adam M Huber
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

8.  Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy.

Authors:  Timothy B Niewold; Silvia N Kariuki; Gabrielle A Morgan; Sheela Shrestha; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2009-06

Review 9.  Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.

Authors:  Lisa G Rider; Katalin Dankó; Frederick W Miller
Journal:  Curr Opin Rheumatol       Date:  2014-11       Impact factor: 5.006

Review 10.  How do autoimmune diseases cluster in families? A systematic review and meta-analysis.

Authors:  Jorge Cárdenas-Roldán; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  BMC Med       Date:  2013-03-18       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.